Position in VTRS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,109,249
+$112,180 QoQ
Shares Held
69,852
-37.4% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#307
of 1,020 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Derivatives in VTRS
reported options exposure · as of Jun 30, 2022CallValue
$0
CallShares
0
PutValue
$1,047,000
PutShares
100,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $2,208,307 across 5 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (50.2% of the industry book) .
All Filings in VTRS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,109,249 | 69,852 | Shares | Sole | 2026-08-13 | |
| 2025-06-30 | $997,069 | 111,654 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $561,751 | 64,495 | Shares | Sole | 2025-05-15 | |
| 2024-09-30 | $600,515 | 51,724 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $179,856 | 18,241 | Shares | Sole | 2023-11-14 | |
| 2022-06-30 | $726,220 | 69,362 | Shares | Sole | 2022-08-17 | |
| 2022-06-30 | $1,047,000 | 100,000 | Put | Sole | 2022-08-17 | |
| 2022-03-31 | $1,088,000 | 100,000 | Put | Sole | 2022-05-16 | |
| 2022-03-31 | $1,088,000 | 100,000 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $507,840 | 37,479 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $595,035 | 41,640 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||